Patched1 deletion increases N-Myc protein stability as a mechanism of medulloblastoma initiation and progression - PubMed (original) (raw)
. 2009 Apr 2;28(13):1605-15.
doi: 10.1038/onc.2009.3. Epub 2009 Feb 23.
Affiliations
- PMID: 19234491
- DOI: 10.1038/onc.2009.3
Patched1 deletion increases N-Myc protein stability as a mechanism of medulloblastoma initiation and progression
W D Thomas et al. Oncogene. 2009.
Abstract
Medulloblastoma tumorigenesis caused by inactivating mutations in the PATCHED1 (PTCH1) gene is initiated by persistently activated Sonic Hedgehog (Shh) signaling in granule neuron precursors (GNPs) during the late stages of cerebellar development. Both normal cerebellar development and Shh-driven medulloblastoma tumorigenesis require N-Myc expression. However, the mechanisms by which N-Myc affects the stages of medulloblastoma initiation and progression are unknown. Here we used a mouse model of Ptch1 heterozygosity and medulloblastoma to show that increased N-Myc expression characterized the earliest selection of focal GNP hyperplasia destined for later tumor progression. Step-wise loss of Ptch1 expression, from tumor initiation to progression, led to incremental increases in N-Myc protein, rather than mRNA, expression. Increased N-Myc resulted in enhanced proliferation and death resistance of perinatal GNPs at tumor initiation. Sequential N-Myc protein phosphorylation at serine-62 and serine-62/threonine-58 characterized the early and late stages of medulloblastoma tumorigenesis, respectively. Shh pathway activation led to increased Myc protein stability and reduced expression of key regulatory factors. Taken together our data identify N-Myc protein stability as the result of loss of Ptch1, which distinguishes normal cerebellar development from medulloblastoma tumorigenesis.
Similar articles
- N-myc is an essential downstream effector of Shh signaling during both normal and neoplastic cerebellar growth.
Hatton BA, Knoepfler PS, Kenney AM, Rowitch DH, de Alborán IM, Olson JM, Eisenman RN. Hatton BA, et al. Cancer Res. 2006 Sep 1;66(17):8655-61. doi: 10.1158/0008-5472.CAN-06-1621. Cancer Res. 2006. PMID: 16951180 - Transcriptional repressor REST drives lineage stage-specific chromatin compaction at Ptch1 and increases AKT activation in a mouse model of medulloblastoma.
Dobson THW, Tao RH, Swaminathan J, Maegawa S, Shaik S, Bravo-Alegria J, Sharma A, Kennis B, Yang Y, Callegari K, Haltom AR, Taylor P, Kogiso M, Qi L, Khatua S, Goldman S, Lulla RR, Fangusaro J, MacDonald TJ, Li XN, Hawkins C, Rajaram V, Gopalakrishnan V. Dobson THW, et al. Sci Signal. 2019 Jan 22;12(565):eaan8680. doi: 10.1126/scisignal.aan8680. Sci Signal. 2019. PMID: 30670636 Free PMC article. - Pituitary adenylyl cyclase activating polypeptide inhibits gli1 gene expression and proliferation in primary medulloblastoma derived tumorsphere cultures.
Cohen JR, Resnick DZ, Niewiadomski P, Dong H, Liau LM, Waschek JA. Cohen JR, et al. BMC Cancer. 2010 Dec 9;10:676. doi: 10.1186/1471-2407-10-676. BMC Cancer. 2010. PMID: 21143927 Free PMC article. - From cerebellar proliferation to tumorigenesis: new insights into the role of Mad3.
Barisone GA, Yun JS, Díaz E. Barisone GA, et al. Cell Cycle. 2008 Feb 15;7(4):423-7. doi: 10.4161/cc.7.4.5413. Epub 2007 Dec 6. Cell Cycle. 2008. PMID: 18235219 Review. - Mouse models of medulloblastoma.
Wu X, Northcott PA, Croul S, Taylor MD. Wu X, et al. Chin J Cancer. 2011 Jul;30(7):442-9. doi: 10.5732/cjc.011.10040. Chin J Cancer. 2011. PMID: 21718590 Free PMC article. Review.
Cited by
- Sonic hedgehog signalling pathway in CNS tumours: its role and therapeutic implications.
Wireko AA, Ben-Jaafar A, Kong JSH, Mannan KM, Sanker V, Rosenke SL, Boye ANA, Nkrumah-Boateng PA, Poornaselvan J, Shah MH, Abdul-Rahman T, Atallah O. Wireko AA, et al. Mol Brain. 2024 Nov 20;17(1):83. doi: 10.1186/s13041-024-01155-w. Mol Brain. 2024. PMID: 39568072 Free PMC article. Review. - Three dimensional reconstruction of the mouse cerebellum in Hedgehog-driven medulloblastoma models to identify Norrin-dependent effects on preneoplasia.
Pokrajac NT, Gurdita A, Tachibana N, Tokarew NJA, Wallace VA. Pokrajac NT, et al. Commun Biol. 2022 Jun 9;5(1):569. doi: 10.1038/s42003-022-03507-5. Commun Biol. 2022. PMID: 35680976 Free PMC article. - Molecular mechanisms of neuroendocrine differentiation in prostate cancer progression.
Xie Y, Ning S, Hu J. Xie Y, et al. J Cancer Res Clin Oncol. 2022 Jul;148(7):1813-1823. doi: 10.1007/s00432-022-04061-7. Epub 2022 May 28. J Cancer Res Clin Oncol. 2022. PMID: 35633416 Free PMC article. Review. - Basal cell carcinomas acquire secondary mutations to overcome dormancy and progress from microscopic to macroscopic disease.
Trieu KG, Tsai SY, Eberl M, Ju V, Ford NC, Doane OJ, Peterson JK, Veniaminova NA, Grachtchouk M, Harms PW, Swartling FJ, Dlugosz AA, Wong SY. Trieu KG, et al. Cell Rep. 2022 May 3;39(5):110779. doi: 10.1016/j.celrep.2022.110779. Cell Rep. 2022. PMID: 35508126 Free PMC article. - Polymeric nanomedicine for overcoming resistance mechanisms in hedgehog and Myc-amplified medulloblastoma.
Kumar V, Wang Q, Sethi B, Lin F, Kumar V, Coulter DW, Dong Y, Mahato RI. Kumar V, et al. Biomaterials. 2021 Nov;278:121138. doi: 10.1016/j.biomaterials.2021.121138. Epub 2021 Sep 29. Biomaterials. 2021. PMID: 34634662 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Molecular Biology Databases